Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings
- PMID: 20010321
- PMCID: PMC2903055
- DOI: 10.1097/IAE.0b013e3181c5970d
Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings
Abstract
Purpose: The purpose of this study was to determine whether fundus autofluorescence (FAF) and spectral domain-optical coherence tomography (SD-OCT) imaging allow better assessment of retinal pigment epithelium and the outer retina in subjects with chronic Vogt-Koyanagi-Harada disease compared with examination and angiography alone.
Methods: A cross-sectional analysis of a series of seven consecutive patients with chronic Vogt-Koyanagi-Harada disease undergoing FAF and SD-OCT was conducted. Chronic disease was defined as duration of intraocular inflammation >3 months. Color fundus photographs were correlated to FAF and SD-OCT images. The images were later correlated to fluorescein angiography and indocyanine green angiography.
Results: All patients had sunset glow fundus, which resulted in no apparent corresponding abnormality on FAF or SD-OCT. Lesions with decreased autofluorescence signal were observed in 11 eyes (85%), being associated with loss of the retinal pigment epithelium and involvement of the outer retina on SD-OCT. In 5 eyes (38%), some of these lesions were very subtle on clinical examination but easily detected by FAF. Lesions with increased autofluorescence signal were seen in 8 eyes (61.5%), showing variable involvement of the outer retina on SD-OCT and corresponding clinically to areas of retinal pigment epithelium proliferation and cystoid macular edema.
Conclusion: Combined use of FAF and SD-OCT imaging allowed noninvasive delineation of retinal pigment epithelium/outer retina changes in patients with chronic Vogt-Koyanagi-Harada disease, which were consistent with previous histopathologic reports. Some of these changes were not apparent on clinical examination.
Figures




Similar articles
-
[Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jan 30;41(1):135-140. doi: 10.12122/j.issn.1673-4254.2021.01.20. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 33509766 Free PMC article. Chinese.
-
Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.Am J Ophthalmol. 2001 May;131(5):607-14. doi: 10.1016/s0002-9394(00)00851-5. Am J Ophthalmol. 2001. PMID: 11336935
-
Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.Ocul Immunol Inflamm. 2025 Feb;33(2):263-270. doi: 10.1080/09273948.2024.2391420. Epub 2024 Aug 27. Ocul Immunol Inflamm. 2025. PMID: 39190826 Clinical Trial.
-
[Pathophysiology of macular diseases--morphology and function].Nippon Ganka Gakkai Zasshi. 2011 Mar;115(3):238-74; discussion 275. Nippon Ganka Gakkai Zasshi. 2011. PMID: 21476310 Review. Japanese.
-
Vogt-Koyanagi-Harada disease.Surv Ophthalmol. 2017 Jan-Feb;62(1):1-25. doi: 10.1016/j.survophthal.2016.05.002. Epub 2016 May 27. Surv Ophthalmol. 2017. PMID: 27241814 Review.
Cited by
-
Fundus Autofluorescence in Posterior and Panuveitis-An Under-Estimated Imaging Technique: A Review and Case Series.Biomolecules. 2024 Apr 25;14(5):515. doi: 10.3390/biom14050515. Biomolecules. 2024. PMID: 38785922 Free PMC article. Review.
-
Use of fundus autofluorescence in the diagnosis and management of uveitis.Int Ophthalmol Clin. 2012 Fall;52(4):45-54. doi: 10.1097/IIO.0b013e3182662ee9. Int Ophthalmol Clin. 2012. PMID: 22954928 Free PMC article. Review. No abstract available.
-
Beyond the Usual Suspects: Unilateral Optic Disc Edema as a Rare Initial Sign of Vogt-Koyanagi-Harada Syndrome.Rom J Ophthalmol. 2025 Apr-Jun;69(2):275-279. doi: 10.22336/rjo.2025.44. Rom J Ophthalmol. 2025. PMID: 40698104 Free PMC article.
-
Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.BMC Ophthalmol. 2012 Aug 13;12:40. doi: 10.1186/1471-2415-12-40. BMC Ophthalmol. 2012. PMID: 22889440 Free PMC article.
-
Rituximab in refractory Vogt-Koyanagi-Harada disease.J Ophthalmic Inflamm Infect. 2011 Dec;1(4):177-80. doi: 10.1007/s12348-011-0027-9. Epub 2011 Jul 9. J Ophthalmic Inflamm Infect. 2011. PMID: 21744181 Free PMC article.
References
-
- Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265–292. - PubMed
-
- Rao NA. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye. 1997;11:213–216. - PubMed
-
- Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652. - PubMed
-
- Beniz J, Forster DJ, Lean JS, et al. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina. 1991;11:275–280. - PubMed
-
- Read RW, Yu F, Accorinti M, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2006;142:119–124. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources